Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteria

被引：1
|
作者：
Tleyjeh, Imad M. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] King Fahad Med City, Dept Med Specialties, Infect Dis Sect, Riyadh, Saudi Arabia
[2] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia
[3] Mayo Clin, Coll Med & Sci, Div Publ Hlth Infect Dis & Occupat Med, Rochester, MN USA
[4] Mayo Clin, Coll Med & Sci, Div Epidemiol, Rochester, MN USA
[5] King Fahd Med City, Sect Infect Dis, POB 59046, Riyadh 11525, Saudi Arabia
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2023年 / 29卷 / 09期
关键词：
Drug resistance; Gram-negative bacteria; Pneumonia; Short-course therapy; Ventilator; Trial design considerations; INFECTIOUS-DISEASES SOCIETY; DURATION; AMERICA;
D O I：
10.1016/j.cmi.2023.04.018
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1114 / 1116
页数：3
相关论文
共 50 条
  • [21] Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective
    Giacobbe, Daniele Roberto
    Roberts, Jason A.
    Abdul-Aziz, Mohd H.
    de Montmollin, Etienne
    Timsit, Jean-Francois
    Bassetti, Matteo
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (07) : 963 - 979
  • [22] Duration of antibiotic therapy for ventilator-associated pneumonia: Comparison of 7 and 10 days. A pilot study
    Hassen, M. Fekih
    Ayed, S.
    Ali, H. Ben Sik
    Gharbi, R.
    Marghli, S.
    Elatrous, S.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2009, 28 (01): : 16 - 23
  • [23] Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial
    Chastre, J
    Wolff, M
    Fagon, JY
    Chevret, S
    Thomas, F
    Wermert, D
    Clementi, E
    Gonzalez, J
    Jusserand, D
    Asfar, P
    Perrin, D
    Fieux, F
    Aubas, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19): : 2588 - 2598
  • [24] Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial
    Liu, Chang
    Zhang, Yu-Ting
    Peng, Zhi-Yong
    Zhou, Qing
    Hu, Bo
    Zhou, Hui
    Li, Jian-Guo
    CHINESE MEDICAL JOURNAL, 2017, 130 (10) : 1196 - 1201
  • [25] Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial
    Liu Chang
    Zhang Yu-Ting
    Peng Zhi-Yong
    Zhou Qing
    Hu Bo
    Zhou Hui
    Li Jian-Guo
    中华医学杂志英文版, 2017, 130 (10) : 1196 - 1201
  • [26] A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia IASIS Trial
    Kollef, Marin H.
    Ricard, Jean-Damien
    Roux, Damien
    Francois, Bruno
    Ischaki, Eleni
    Rozgonyi, Zsolt
    Boulain, Thierry
    Ivanyi, Zsolt
    Janos, Gal
    Garot, Denis
    Koura, Firas
    Zakynthinos, Epaminondas
    Dimopoulos, George
    Torres, Antonio
    Danker, Wayne
    Montgomery, A. Bruce
    CHEST, 2017, 151 (06) : 1239 - 1246
  • [27] Efficacy of an intravenous colistin regimen in ventilator-associated pneumonia and bacteraemia due to multiresistant Gram-negative bacteria: preliminary results
    F Frantzeskaki
    A Tsimogianni
    M Balla
    A Betrosian
    Critical Care, 10 (Suppl 1):
  • [28] Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Vietnam: Antibiotic Resistance, Treatment Outcomes, and Colistin-Associated Adverse Effects
    Thu Pham Minh Vo
    Thien Chi Dinh
    Hung Viet Phan
    Thuy Thi My Cao
    Phuoc Thien Duong
    Thang Nguyen
    HEALTHCARE, 2022, 10 (09)
  • [29] Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant Gram-negative bacteria
    Kollef, Katherhie E.
    Schramm, Garrett E.
    Wills, Angela R.
    Reichley, Richard M.
    Micek, Scott T.
    Kollef, Marin H.
    CHEST, 2008, 134 (02) : 281 - 287
  • [30] An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria
    Cilloniz, Catia
    Dominedo, Cristina
    Torres, Antoni
    CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (06) : 656 - 662
12345